Literature DB >> 34033582

Proof-of-Concept Support for the Development and Implementation of a Digital Assessment for Perinatal Mental Health: Mixed Methods Study.

Nayra Anna Martin-Key1, Benedetta Spadaro1, Thea Sofie Schei2, Sabine Bahn1.   

Abstract

BACKGROUND: Perinatal mental health symptoms commonly remain underdiagnosed and undertreated in maternity care settings in the United Kingdom, with outbreaks of disease, like the COVID-19 pandemic, further disrupting access to adequate mental health support. Digital technologies may offer an innovative way to support the mental health needs of women and their families throughout the perinatal period, as well as assist midwives in the recognition of perinatal mental health concerns. However, little is known about the acceptability and perceived benefits and barriers to using such technologies.
OBJECTIVE: The aim of this study was to conduct a mixed methods evaluation of the current state of perinatal mental health care provision in the United Kingdom, as well as users' (women and partners) and midwives' interest in using a digital mental health assessment throughout the perinatal period.
METHODS: Women, partners, and midwives were recruited to participate in the study, which entailed completing an online survey. Quantitative data were explored using descriptive statistics. Open-ended response data were first investigated using thematic analysis. Resultant themes were then mapped onto the components of the Capability, Opportunity, and Motivation Behavior model and summarized using descriptive statistics.
RESULTS: A total of 829 women, 103 partners, and 90 midwives participated in the study. The provision of adequate perinatal mental health care support was limited, with experiences varying significantly across respondents. There was a strong interest in using a digital mental health assessment to screen, diagnose, and triage perinatal mental health concerns, particularly among women and midwives. The majority of respondents (n=781, 76.42%) expressed that they would feel comfortable or very comfortable using or recommending a digital mental health assessment. The majority of women and partners showed a preference for in-person consultations (n=417, 44.74%), followed by a blended care approach (ie, both in-person and online consultations) (n=362, 38.84%), with fewer participants preferring online-only consultations (n=120, 12.88%). Identified benefits and barriers mainly related to physical opportunity (eg, accessibility), psychological capability (eg, cognitive skills), and automatic motivation (eg, emotions).
CONCLUSIONS: This study provides proof-of-concept support for the development and implementation of a digital mental health assessment to inform clinical decision making in the assessment of perinatal mental health concerns in the United Kingdom. ©Nayra Anna Martin-Key, Benedetta Spadaro, Thea Sofie Schei, Sabine Bahn. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 04.06.2021.

Entities:  

Keywords:  COM-B; COVID-19; assessment; development; digital mental health; implementation; maternal mental health; mental health; mother; paternal mental health; perinatal mental health; support; women

Year:  2021        PMID: 34033582     DOI: 10.2196/27132

Source DB:  PubMed          Journal:  J Med Internet Res        ISSN: 1438-8871            Impact factor:   5.428


  2 in total

1.  COVID-19 in the context of pregnancy, infancy and parenting (CoCoPIP) study: protocol for a longitudinal study of parental mental health, social interactions, physical growth and cognitive development of infants during the pandemic.

Authors:  Ezra Aydin; Staci M Weiss; Kevin A Glasgow; Jane Barlow; Topun Austin; Mark H Johnson; Sarah Lloyd-Fox
Journal:  BMJ Open       Date:  2022-06-06       Impact factor: 3.006

Review 2.  mHealth Solutions for Perinatal Mental Health: Scoping Review and Appraisal Following the mHealth Index and Navigation Database Framework.

Authors:  Benedetta Spadaro; Nayra A Martin-Key; Erin Funnell; Sabine Bahn
Journal:  JMIR Mhealth Uhealth       Date:  2022-01-17       Impact factor: 4.773

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.